Vaxil Bio Stock Today
| VXL Stock | CAD 0.01 0.01 50.00% |
Performance1 of 100
| Odds Of DistressOver 84
|
Vaxil Bio is selling for under 0.015 as of the 19th of April 2024; that is 50.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.015. Vaxil Bio has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Vaxil Bio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Vaxil Bio Ltd., an immunotherapy biotech company, engages in the research and development of immunotherapies for cancer and infectious diseases in Israel. The company was founded in 2006 and is headquartered in Toronto, Canada. VAXIL BIO is traded on TSX Venture Exchange in Canada.. The company has 136.98 M outstanding shares of which 19.99 K shares are at this time shorted by private and institutional investors with about 0.13 days to cover all short positions. More on Vaxil Bio
Moving against Vaxil Stock
| 0.86 | CNQ | Canadian Natural Res | PairCorr |
| 0.85 | VCM | Vecima Networks | PairCorr |
| 0.81 | ASM | Avino Silver Gold | PairCorr |
| 0.67 | MOX | Morien Resources Corp | PairCorr |
| 0.43 | NXE | NexGen Energy | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Vaxil Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vaxil Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaxil Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Chairman | David Goren | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Vaxil Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Vaxil Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vaxil Bio's financial leverage. It provides some insight into what part of Vaxil Bio's total assets is financed by creditors.
| |||||
Vaxil Bio (VXL) is traded on TSX Venture Exchange in Canada and employs 3 people. Vaxil Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxil Bio's market, we take the total number of its shares issued and multiply it by Vaxil Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vaxil Bio classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 136.98 M outstanding shares of which 19.99 K shares are at this time shorted by private and institutional investors with about 0.13 days to cover all short positions.
Vaxil Bio has accumulated about 307 K in cash with (675 K) of positive cash flow from operations.
Check Vaxil Bio Probability Of Bankruptcy
Ownership AllocationVaxil Bio maintains a total of 136.98 Million outstanding shares. Vaxil Bio has 8.16 % of its outstanding shares held by insiders and 0.01 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Vaxil Ownership Details
Vaxil Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Vaxil Bio jumping above the current price in 90 days from now is about 75.6%. The Vaxil Bio probability density function shows the probability of Vaxil Bio stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the stock has a beta coefficient of 1.4399. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vaxil Bio will likely underperform. Additionally, vaxil Bio has an alpha of 0.2339, implying that it can generate a 0.23 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Vaxil Bio to move above the current price in 90 days from now is about 75.6 (This Vaxil Bio probability density function shows the probability of Vaxil Stock to fall within a particular range of prices over 90 days) .
Vaxil Bio Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Vaxil Bio market risk premium is the additional return an investor will receive from holding Vaxil Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vaxil Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Vaxil Bio's alpha and beta are two of the key measurements used to evaluate Vaxil Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.02 | |||
| Semi Deviation | 9.45 | |||
| Standard Deviation | 15.42 | |||
| Variance | 237.88 |
Vaxil Stock Against Markets
Picking the right benchmark for Vaxil Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vaxil Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vaxil Bio is critical whether you are bullish or bearish towards Vaxil Bio at a given time. Please also check how Vaxil Bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vaxil Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
How to buy Vaxil Stock?
Before investing in Vaxil Bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vaxil Bio. To buy Vaxil Bio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vaxil Bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vaxil Bio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vaxil Bio stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vaxil Bio stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vaxil Bio, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Vaxil Bio?
The danger of trading Vaxil Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vaxil Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vaxil Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vaxil Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Vaxil Stock analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |